Sale!

MAT1A Gene Methionine Adenosyltransferase Deficiency Autosomal Recessive Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The MAT1A gene plays a critical role in the body by encoding the enzyme methionine adenosyltransferase, which is essential for the biosynthesis of S-adenosylmethionine, a critical methyl donor involved in numerous metabolic processes. Deficiency in this enzyme due to mutations in the MAT1A gene can lead to a range of metabolic disorders, including hypermethioninemia, characterized by elevated methionine levels in the blood. This condition can have various clinical manifestations, from benign to severe neurological symptoms.

To diagnose this deficiency, a genetic test targeting the MAT1A gene can be conducted. This test is crucial for identifying mutations in the MAT1A gene that lead to methionine adenosyltransferase deficiency. The genetic test for MAT1A gene methionine adenosyltransferase deficiency is available at DNA Labs UAE, a facility equipped with advanced diagnostic technologies to provide accurate genetic testing services. The cost of the test is 4400 AED, and it involves analyzing the patient’s DNA sample to detect mutations in the MAT1A gene. This test is particularly important for individuals with a family history of metabolic disorders or those exhibiting symptoms related to methionine adenosyltransferase deficiency, as early diagnosis can facilitate timely management and treatment strategies to mitigate the impact of the condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MAT1A Gene Methionine Adenosyltransferase Deficiency Autosomal Recessive Genetic Test

Test Name: MAT1A Gene Methionine Adenosyltransferase Deficiency Autosomal Recessive Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for MAT1A Gene Methionine Adenosyltransferase Deficiency, Autosomal Recessive NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MAT1A Gene Methionine Adenosyltransferase Deficiency, Autosomal Recessive

Test Details

MAT1A gene methionine adenosyltransferase deficiency is a rare autosomal recessive disorder that affects the production of an enzyme called methionine adenosyltransferase (MAT). This enzyme is responsible for the synthesis of S-adenosylmethionine (SAMe), which is involved in various biochemical reactions in the body.

A genetic test using next-generation sequencing (NGS) can be performed to identify mutations or variants in the MAT1A gene. NGS is a high-throughput DNA sequencing technology that allows for the simultaneous analysis of multiple genes or the entire genome. This test can help in the diagnosis of MAT1A gene methionine adenosyltransferase deficiency by identifying specific genetic changes in the MAT1A gene that may be causing the disorder.

The test involves obtaining a DNA sample, usually through a blood sample or a cheek swab, from the individual suspected of having the condition. The DNA is then sequenced using NGS technology to identify any mutations or variants in the MAT1A gene.

The results of the test can help confirm the diagnosis and guide treatment options for affected individuals. It is important to note that genetic testing for MAT1A gene methionine adenosyltransferase deficiency is typically performed in specialized laboratories and requires a healthcare professional’s involvement. Genetic counseling may also be recommended to help individuals and families understand the implications of the test results and make informed decisions about their healthcare.

Overall, NGS genetic testing for MAT1A gene methionine adenosyltransferase deficiency can provide valuable information for diagnosis, treatment, and genetic counseling for individuals and families affected by this rare genetic disorder.

Test Name MAT1A Gene Methionine adenosyltransferase deficiency autosomal recessive Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for MAT1A Gene Methionine adenosyltransferase deficiency, autosomal recessive NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with MAT1A Gene Methionine adenosyltransferase deficiency, autosomal recessive
Test Details

MAT1A gene methionine adenosyltransferase deficiency is a rare autosomal recessive disorder that affects the production of an enzyme called methionine adenosyltransferase (MAT). This enzyme is responsible for the synthesis of S-adenosylmethionine (SAMe), which is involved in various biochemical reactions in the body.

A genetic test using next-generation sequencing (NGS) can be performed to identify mutations or variants in the MAT1A gene. NGS is a high-throughput DNA sequencing technology that allows for the simultaneous analysis of multiple genes or the entire genome. This test can help in the diagnosis of MAT1A gene methionine adenosyltransferase deficiency by identifying specific genetic changes in the MAT1A gene that may be causing the disorder.

The test involves obtaining a DNA sample, usually through a blood sample or a cheek swab, from the individual suspected of having the condition. The DNA is then sequenced using NGS technology to identify any mutations or variants in the MAT1A gene. The results of the test can help confirm the diagnosis and guide treatment options for affected individuals.

It is important to note that genetic testing for MAT1A gene methionine adenosyltransferase deficiency is typically performed in specialized laboratories and requires a healthcare professional’s involvement. Genetic counseling may also be recommended to help individuals and families understand the implications of the test results and make informed decisions about their healthcare.

Overall, NGS genetic testing for MAT1A gene methionine adenosyltransferase deficiency can provide valuable information for diagnosis, treatment, and genetic counseling for individuals and families affected by this rare genetic disorder.